ATE459883T1 - Neue proliferationsmarker in der klinischen praxis und deren verwendung zur krebsprognose oder -diagnose - Google Patents
Neue proliferationsmarker in der klinischen praxis und deren verwendung zur krebsprognose oder -diagnoseInfo
- Publication number
- ATE459883T1 ATE459883T1 AT05715950T AT05715950T ATE459883T1 AT E459883 T1 ATE459883 T1 AT E459883T1 AT 05715950 T AT05715950 T AT 05715950T AT 05715950 T AT05715950 T AT 05715950T AT E459883 T1 ATE459883 T1 AT E459883T1
- Authority
- AT
- Austria
- Prior art keywords
- diagnosis
- cancer prognosis
- proliferation markers
- clinical practice
- new proliferation
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 238000004393 prognosis Methods 0.000 title abstract 2
- 230000035755 proliferation Effects 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title 1
- 102000008868 Chromatin Assembly Factor-1 Human genes 0.000 abstract 2
- 108010088529 Chromatin Assembly Factor-1 Proteins 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54811104P | 2004-02-27 | 2004-02-27 | |
| PCT/EP2005/002578 WO2005085860A2 (en) | 2004-02-27 | 2005-02-28 | New proliferation markers in clinical practice and their use for cancer prognosis or diagnosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE459883T1 true ATE459883T1 (de) | 2010-03-15 |
Family
ID=34919336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05715950T ATE459883T1 (de) | 2004-02-27 | 2005-02-28 | Neue proliferationsmarker in der klinischen praxis und deren verwendung zur krebsprognose oder -diagnose |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7781174B2 (de) |
| EP (1) | EP1721165B1 (de) |
| JP (1) | JP4848355B2 (de) |
| AT (1) | ATE459883T1 (de) |
| CA (1) | CA2555656C (de) |
| DE (1) | DE602005019694D1 (de) |
| WO (1) | WO2005085860A2 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1999253B1 (de) | 2006-03-02 | 2019-05-22 | Viacyte, Inc. | Endokrine vorläuferzellen, pankreashormon-exprimierende zellen und herstellungsverfahren |
| US11254916B2 (en) | 2006-03-02 | 2022-02-22 | Viacyte, Inc. | Methods of making and using PDX1-positive pancreatic endoderm cells |
| JP5180084B2 (ja) * | 2006-09-19 | 2013-04-10 | 日本ケミカルリサーチ株式会社 | がん細胞識別マーカー及びがん細胞増殖阻害剤 |
| AU2008257771B2 (en) | 2007-05-30 | 2015-02-19 | F. Hoffmann-La Roche Ag | Non-nucleoside reverse transcriptase inhibitors |
| WO2009126543A1 (en) | 2008-04-08 | 2009-10-15 | Nuclea Biomarkers, Llc | Biomarker panel for prediction of recurrent colorectal cancer |
| EP2243843A1 (de) * | 2009-04-24 | 2010-10-27 | Institut Curie | HP1-Alpha als prognostischer Marker bei Krebserkrankungen des Menschen |
| US20130149320A1 (en) | 2010-05-31 | 2013-06-13 | Centre National De La Recherche Scientifique | Asf1b as a Prognosis Marker and Therapeutic Target in Human Cancer |
| EP2702173A1 (de) | 2011-04-25 | 2014-03-05 | OSI Pharmaceuticals, LLC | Verwendung von emt-gensignaturen bei der entdeckung von krebswirkstoffen, -diagnostika und -behandlungen |
| EP4060344A1 (de) | 2015-06-08 | 2022-09-21 | Arquer Diagnostics Limited | Verfahren und kits |
| WO2016198833A2 (en) | 2015-06-08 | 2016-12-15 | Arquer Diagnostics Limited | Methods |
| US10839509B2 (en) | 2015-07-10 | 2020-11-17 | 3Scan Inc. | Spatial multiplexing of histological stains |
| CA3058406A1 (en) | 2017-03-30 | 2018-10-04 | The Board Of Trustees Of The University Of Illinois | Method and kit for diagnosing early stage pancreatic cancer |
| US12153054B2 (en) | 2018-02-28 | 2024-11-26 | Nitto Boseki Co., Ltd. | Method for isolating cell nuclei having enhanced antigenicity from fixed cells or FFPE tissue section, and antigen activator and kit therefor |
| CN111766385B (zh) * | 2020-07-06 | 2023-09-26 | 河南赛诺特生物技术有限公司 | 术中快速鉴别肺癌和硬化性肺细胞瘤的免疫组化试剂盒 |
| CN113984483B (zh) * | 2021-09-28 | 2023-10-20 | 福建医科大学 | 一种冰冻切片盖玻片贴片染色方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6071715A (en) * | 1993-08-12 | 2000-06-06 | Board Of Regents, The University Of Texas System | Nucleic acids encoding novel proteins which bind to retinoblastoma protein |
| CN100342030C (zh) * | 2000-11-24 | 2007-10-10 | 卫材R&D管理有限公司 | 试验肿瘤细胞对于抗癌药剂敏感性的方法 |
| CA2459219A1 (en) * | 2001-09-17 | 2003-03-27 | Protein Design Labs, Inc. | Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer |
| AU2003217774A1 (en) * | 2002-02-28 | 2003-09-16 | Georgetown University | Method and composition for detection and treatment of breast cancer |
-
2005
- 2005-02-28 DE DE602005019694T patent/DE602005019694D1/de not_active Expired - Lifetime
- 2005-02-28 EP EP05715950A patent/EP1721165B1/de not_active Expired - Lifetime
- 2005-02-28 CA CA2555656A patent/CA2555656C/en not_active Expired - Fee Related
- 2005-02-28 AT AT05715950T patent/ATE459883T1/de not_active IP Right Cessation
- 2005-02-28 WO PCT/EP2005/002578 patent/WO2005085860A2/en not_active Ceased
- 2005-02-28 JP JP2007500191A patent/JP4848355B2/ja not_active Expired - Fee Related
-
2006
- 2006-08-28 US US11/510,612 patent/US7781174B2/en not_active Expired - Fee Related
-
2010
- 2010-06-03 US US12/792,855 patent/US20110003706A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1721165A2 (de) | 2006-11-15 |
| EP1721165B1 (de) | 2010-03-03 |
| US20110003706A1 (en) | 2011-01-06 |
| US20070077577A1 (en) | 2007-04-05 |
| CA2555656C (en) | 2017-03-28 |
| CA2555656A1 (en) | 2005-09-15 |
| JP2007524103A (ja) | 2007-08-23 |
| WO2005085860A3 (en) | 2005-11-10 |
| JP4848355B2 (ja) | 2011-12-28 |
| WO2005085860A2 (en) | 2005-09-15 |
| US7781174B2 (en) | 2010-08-24 |
| DE602005019694D1 (de) | 2010-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE459883T1 (de) | Neue proliferationsmarker in der klinischen praxis und deren verwendung zur krebsprognose oder -diagnose | |
| Saikhedkar et al. | Effects of mobile phone radiation (900 MHz radiofrequency) on structure and functions of rat brain | |
| WO2008091814A3 (en) | Assessment of asthma and allergen-dependent gene expression | |
| DK1666052T3 (da) | Anti-APRIL monoklonalt antistof og dets anvendelse til behandling af en immum-relateret sygdom eller cancer | |
| ATE490465T1 (de) | Diagnose- und prognoseverfahren von blasenkrebs. | |
| WO2007092433A3 (en) | Osteoporosis associated markers and methods of use thereof | |
| WO2008109414A3 (en) | Use of endogenous fluorescence to identify invading metastatic breast tumor cells | |
| NO20074817L (no) | Epidermal vekstfaktorreseptor genkopiantall | |
| ATE454468T1 (de) | Nachweis der instabilität von mikrosatelliten und verwendung davon bei der tumordiagnose | |
| NZ578283A (en) | Proteomic profiling method useful for condition diagnosis and monitoring, composition screening, and therapeutic monitoring | |
| WO2006065943A3 (en) | In-vivo monitoring of circulating apoptotic cells | |
| WO2010118166A3 (en) | Methods of predicting cancer risk using gene expression in premalignant tissue | |
| MX2020002122A (es) | Sustancias de control de calidad para uso con analizadores de sedimentos en orina basados en microscopia, y metodos de uso. | |
| BR0317394A (pt) | Uso de nicotinamida n-metiltransferase como um marcador para câncer colorretal | |
| EP3894868A4 (de) | Kombinatorische zeitliche biomarker und präzisionsarzneimittel mit detektions- und behandlungsmethoden zur verwendung bei nervenläsionen, nervenerkrankungen und nervenreparaturen | |
| DE602005014386D1 (de) | Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome | |
| ATE479898T1 (de) | Reagenzien und verfahren zur verwendung bei der diagnose, klassifizierung und behandlung von krebs | |
| ATE545867T1 (de) | I-plastin-testverfahren zur in-vitro-diagnose von kolorektalkarzinom | |
| WO2013072584A3 (fr) | Méthode de caractérisation de cellules tumorales circulantes et application au diagnostic | |
| PE20120592A1 (es) | Metodo con biomarcadores para el seguimiento de un tratamiento | |
| ATE512146T1 (de) | Phenylharnstoffderivate als hemmstoffe von tyrosinkinasen zur behandlung von tumorerkrankungen | |
| ATE468535T1 (de) | Verwendung von nnmt als marker für lungenkrebs | |
| EP1937831A4 (de) | Verwendung von n-myristoyltransferase auf nichttumorgewebe zur krebsdiagnose | |
| WO2014146035A3 (en) | Compositions and methods for cancer diagnosis | |
| EA200802356A1 (ru) | Способ выявления и диагностики злокачественного новообразования, включающий праймеры и зонды для специфичного выявления маркера mage-a3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |